These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905 [TBL] [Abstract][Full Text] [Related]
3. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here? Stevens JL Chem Res Toxicol; 2006 Nov; 19(11):1393-401. PubMed ID: 17112225 [TBL] [Abstract][Full Text] [Related]
4. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing. Kroeger M Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220 [TBL] [Abstract][Full Text] [Related]
5. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells. Noor F; Niklas J; Müller-Vieira U; Heinzle E Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084 [TBL] [Abstract][Full Text] [Related]
6. [Cellular and molecular pharmacology. A new approach to the mode of action and the toxicity of medications]. Deysson G; Migne J Biol Med (1971); 1974 Jun; 3(1):21-63. PubMed ID: 4470700 [No Abstract] [Full Text] [Related]
8. [Different viewpoints on preclinical immunotoxicologic tests in vivo and in vitro]. Procházková J; Jílek P; Vancurová M Cesk Farm; 1989 Jul; 38(5):233-5. PubMed ID: 2790991 [No Abstract] [Full Text] [Related]
9. The use of hematologic parameters in applying the principles of toxicity testing to biotechnology products. Payne BJ Prog Clin Biol Res; 1987; 235():107-20. PubMed ID: 3601999 [No Abstract] [Full Text] [Related]
10. Cellular systems for toxicity testing. Ann N Y Acad Sci; 1983; 407():1-484. PubMed ID: 6576676 [No Abstract] [Full Text] [Related]
12. Assessment of drug induced developmental toxicity using human embryonic stem cells. Mehta A; Konala VB; Khanna A; Majumdar AS Cell Biol Int; 2008 Nov; 32(11):1412-24. PubMed ID: 18778783 [TBL] [Abstract][Full Text] [Related]
13. Single dose toxicity and repeated dose toxicity studies: introductory remarks. Kurokawa Y; Matsuzawa T J Toxicol Sci; 1996 Dec; 21(5):413-6. PubMed ID: 9035047 [No Abstract] [Full Text] [Related]
14. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective. Buckley LA; Dorato MA Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212 [TBL] [Abstract][Full Text] [Related]
15. International Workshop on the Use of Pharmacological Methods in Safety-Evaluation of New Drugs, 1977. Proceedings. Pharmacol Ther B; 1979; 5(1-3):1-605. PubMed ID: 493303 [No Abstract] [Full Text] [Related]
16. The significance of mitochondrial toxicity testing in drug development. Dykens JA; Will Y Drug Discov Today; 2007 Sep; 12(17-18):777-85. PubMed ID: 17826691 [TBL] [Abstract][Full Text] [Related]
17. A behavioural test applied in an acute toxicity screen [proceedings]. Silverman AP Br J Pharmacol; 1978 Jun; 63(2):349P-350P. PubMed ID: 667432 [No Abstract] [Full Text] [Related]
18. Toxicity testing, hazard assessment and data quality assurance for chemical regulatory purposes. Noel PR Dev Toxicol Environ Sci; 1980; 8():453-63. PubMed ID: 7308045 [No Abstract] [Full Text] [Related]
19. Impact of genetics on toxicity testing, introductory remarks. Hedrich HJ; Löscher W J Exp Anim Sci; 1993 Sep; 35(5-6):197-9. PubMed ID: 8218434 [No Abstract] [Full Text] [Related]
20. Understanding mechanisms of toxicity: insights from drug discovery research. Houck KA; Kavlock RJ Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]